DR. SAPTARSHI BHATTACHARYA

Chief Medical Advisor, Earlyfit

Indraprastha Apollo Hospitals

Senior Consultant, Endocrinology

Current

Max Super Speciality Hospitals (Delhi)

Director - Endocrinology

Past

AIIMS

Former Senior Resident(DM - Endocrinology)

Maulana Azad Medical College (MD)

Former Resident(MD - Medicine)

DR. SAPTARSHI BHATTACHARYA

Chief Medical Advisor, Earlyfit

Indraprastha Apollo Hospitals

Senior Consultant, Endocrinology

Current

Max Super Speciality Hospitals (Delhi)

Director - Endocrinology

Past

AIIMS

Former Senior Resident(DM - Endocrinology)

Maulana Azad Medical College (MD)

Former Resident(MD - Medicine)

About Dr. Bhattacharya

Senior Consultant Endocrinology at Indraprastha Apollo Hospitals (Delhi). He trained at AIIMS (DM in Endocrinology), MAMC (MD in Medicine) and was previously Head of Department of Endocrinology at Max Hospital, Patparganj.

Chief Medical Advisor, EarlyFit. He architects our clinical protocols that combine advanced diagnostics, individualized drug titration, and coordinated multidisciplinary support, all anchored in patient-first care.

20+ years of clinical expertise in endocrinology, with advanced training from AIIMS (DM) and Maulana Azad Medical College (MD).

Fellow of the American College of Endocrinology, with executive leadership roles in national and international endocrine societies.

120+ peer-reviewed publications spanning diabetes, thyroid disorders, PCOS, obesity, and metabolic syndromes.

Here's straight from Dr. Saptarshi Bhattacharya

Research & Recognitions

Efficacy and Safety of Novel Twincretin Tirzepatide, a Dual GIP/GLP-1 Receptor Agonist, as an Anti-obesity Medicine in Individuals Without Diabetes: A Systematic Review and Meta-analysis

Systematic Review • GLP-1 & Obesity

touchREV Endocrinol • 2024

Dutta D, Kamrul-Hasan ABM, Nagendra L, Bhattacharya S. (2024). Efficacy and Safety of Novel Twincretin Tirzepatide, a Dual GIP/GLP-1 Receptor Agonist... touchREV Endocrinol, 20(2):72-80.

Efficacy and safety of albiglutide, a once-weekly glucagon-like peptide-1 receptor agonist, in patients with type 2 diabetes: A systematic review and meta-analysis

Systematic Review • GLP-1 in Diabetes

Medicine (Baltimore) • 2024

Kamrul-Hasan ABM, Dutta D, Nagendra L, Bhattacharya S, Singla R, Kalra S. (2024). Efficacy and safety of albiglutide... Medicine (Baltimore), 103(25):e38568.